WebIntroduction. The dipeptidyl peptidase 4 (DPP-4) inhibitor vildagliptin increases the sensitivity of the α and β cells to glucose, resulting in glucose-dependent secretion of insulin and glucagon, which underlies its improvement of glucose control in patients with type 2 diabetes mellitus (T2DM), as well as its low risk of causing hypoglycemia. 1 Preservation … Web26 Aug 2012 · C-peptide levels are elevated in sulfonylurea exposure, both in therapeutic use and in overdose, due to sulfonylurea-induced endogenous pancreatic insulin release. 42,43 Interpretation of elevated C-peptide levels in sulfonylurea toxicity is not affected by treatment of hypoglycemia; thus, these labs may be drawn after initial ED treatment. 43 …
Hypoglycemia Secondary to Trimethoprim/Sulfamethoxazole …
WebHypoglycemia resulting from the combination of sulfonylureas and sulfonamides is a recognized drug interaction. Hypoglycemia induced by sulfonamides alone may be encountered less frequently. Previously reported cases of TMP/SMX-induced hypoglycemia postulated that the sulfonamide mimics hypoglycemic sulfonylurea agents and … Web3 Aug 2024 · Octreotide should be considered first-line therapy in both pediatric and adult sulfonylurea poisoning with clinical and laboratory evidence of hypoglycemia. The … lower back problems
Risk of severe hypoglycemia in sulfonylurea-treated …
Web21 Sep 2016 · Hypoglycemia is a serious and potentially lethal problem for all patients, particularly the frail elderly. Stay alert for factors that can cause hypoglycemia in these patients—sulfonylureas, polypharmacy, illness, declining kidney function, skipped meals, increased activity or exercise, and previous hypoglycemic events. WebWe present a case series of 6 patients with sulfonylurea-induced hypoglycemia, along with pertinent serial laboratory data and review of the course of management. Results Most of … Web1 Jun 1999 · A diabetic patient with chronic renal failure who ingested excessive amounts of sulfonylurea medications causing refractory hypoglycemia resistant to treatment with large doses of intravenous dextrose is presented. 1 Use of Octreotide to Treat Prolonged Sulfonylurea-induced Hypoglycemia in a Patient with Chronic Renal Failure lower back problems causes